High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
复制标题
DOI:
10.1016/j.ijid.2021.08.062
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
Osoro E
中科院分区:
文献类型:
--
作者:
Ngere I;Dawa J;Hunsperger E;Otieno N;Masika M;Amoth P;Makayotto L;Nasimiyu C;Gunn BM;Nyawanda B;Oluga O;Ngunu C;Mirieri H;Gachohi J;Marwanga D;Munywoki PK;Odhiambo D;Alando MD;Breiman RF;Anzala O;Njenga MK;Bulterys M;Herman-Roloff A;Osoro E
The lower than expected COVID-19 morbidity and mortality in Africa has been attributed to multiple factors, including weak surveillance. This study estimated the burden of SARS-CoV-2 infections eight months into the epidemic in Nairobi, Kenya. A population-based, cross-sectional survey was conducted using multi-stage random sampling to select households within Nairobi in November 2020. Sera from consenting household members were tested for antibodies to SARS-CoV-2. Seroprevalence was estimated after adjusting for population structure and test performance. Infection fatality ratios (IFRs) were calculated by comparing study estimates with reported cases and deaths. Among 1,164 individuals, the adjusted seroprevalence was 34.7% (95% CI 31.8-37.6). Half of the enrolled households had at least one positive participant. Seropositivity increased in more densely populated areas (spearman's r=0.63; p=0.009). Individuals aged 20-59 years had at least two-fold higher seropositivity than those aged 0-9 years. The IFR was 40 per 100,000 infections, with individuals ≥60 years old having higher IFRs. Over one-third of Nairobi residents had been exposed to SARS-CoV-2 by November 2020, indicating extensive transmission. However, the IFR was >10-fold lower than that reported in Europe and the USA, supporting the perceived lower morbidity and mortality in sub-Saharan Africa.
登录
查看更多内容
DOI:
10.4269/ajtmh.20-0816
发表时间:
2020-11
期刊:
The American journal of tropical medicine and hygiene
影响因子:
--
作者:
Kempen JH;Abashawl A;Suga HK;Nigussie Difabachew M;Kempen CJ;Tesfaye Debele M;Menkir AA;Assefa MT;Asfaw EH;Habtegabriel LB;Sitotaw Addisie Y;Nilles EJ;Longenecker JC
通讯作者:
Longenecker JC
DOI:
10.1016/j.jcv.2020.104710
发表时间:
2021-01
期刊:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
影响因子:
--
作者:
Abdelmoniem R;Fouad R;Shawky S;Amer K;Elnagdy T;Hassan WA;Ali AM;Ezzelarab M;Gaber Y;Badary HA;Musa S;Talaat H;Kassem AM;Tantawi O
通讯作者:
Tantawi O
影响因子:
4.5
作者:
Gibbons, Cheryl L.;Mangen, Marie-Josee J.;Kretzschmar, Mirjam E. E.
通讯作者:
Kretzschmar, Mirjam E. E.
影响因子:
3.7
作者:
Halatoko WA;Konu YR;Gbeasor-Komlanvi FA;Sadio AJ;Tchankoni MK;Komlanvi KS;Salou M;Dorkenoo AM;Maman I;Agbobli A;Wateba MI;Adjoh KS;Goeh-Akue E;Kao YB;Kpeto I;Pana P;Kinde-Sossou R;Tamekloe A;Nayo-Apétsianyi J;Assane SH;Prine-David M;Awoussi SM;Djibril M;Mijiyawa M;Dagnra AC;Ekouevi DK
通讯作者:
Ekouevi DK
影响因子:
16.6
作者:
GeurtsvanKessel, Corine H.;Okba, Nisreen M. A.;Koopmans, Marion
通讯作者:
Koopmans, Marion